Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P231
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pico de Coaña, Yago
Poschke, Isabel
Yoshimoto, Yuya
Karlberg, Sara
Nyström, Maria
Wolodarski, Maria
Hansson, Johan
Masucci, Giuseppe
Kiessling, Rolf
Article History
First Online: 6 November 2014